DOD Biotech Public Company Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was THB 678.15 million compared to THB 537.16 million a year ago. Revenue was THB 710.1 million compared to THB 548.33 million a year ago.

Net income was THB 7.19 million compared to net loss of THB 398.33 million a year ago. Basic earnings per share from continuing operations was THB 0.05 compared to basic loss per share from continuing operations of THB 0.84 a year ago. Basic earnings per share was THB 0.02 compared to basic loss per share of THB 0.97 a year ago.